Open AccessResponse to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
Author(s) -
Charlene M. Prazma,
Marco Idzko,
Jo A Douglass,
Arnaud Bourdin,
Stephen Mallett,
Frank Albers,
Steven W. Yancey
Publication year - 2021
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s298559
Subject(s) - medicine , atopy , mepolizumab , asthma , placebo , eosinophil , atopic dermatitis , eosinophil cationic protein , immunology , immunoglobulin e , gastroenterology , antibody , pathology , alternative medicine
Improved understanding of characteristics that may influence treatment response across phenotypes may help guide treatment decisions.